<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2679">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04332016</url>
  </required_header>
  <id_info>
    <org_study_id>CHUBX 2020/11</org_study_id>
    <nct_id>NCT04332016</nct_id>
  </id_info>
  <brief_title>COVID-19 Biological Samples Collection</brief_title>
  <acronym>COLCOV19-BX</acronym>
  <official_title>Biological Samples Collection From Patients and Caregivers Treated at Bordeaux University Hospital for Asymptomatic and Symptomatic Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) Infection (COVID-19).</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Bordeaux</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Bordeaux</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The coronavirus disease 2019 (COVID-19) outbreak is now considered as a public health
      emergency of international concern by the World Health Organization.

      In the context of the health emergency, research on the pathogen (the SARS-CoV-2
      coronavirus), the disease and the therapeutic care is being organized. Research projects
      require the use of biological samples. This study aims at setting up a collection of
      biological samples intended for application projects in any discipline.

      The main objective of the study is to collect, process and store biological samples from
      patients and caregivers infected with SARS-CoV-2 (COVID-19) at the biological ressources
      center of the Bordeaux University Hospital.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 2, 2020</start_date>
  <completion_date type="Anticipated">March 2023</completion_date>
  <primary_completion_date type="Anticipated">March 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>COVID-19 desease description</measure>
    <time_frame>Inclusion visit (Day 1)</time_frame>
    <description>From blood samples: protein levels, whole genome sequence, transcriptomic analysis data.
From upper respiratory samples: protein levels, virus transcriptomic analysis data.
From stool: microbiota analysis data.
From urine: protein level.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>COVID-19 desease description</measure>
    <time_frame>Day 30 to 90</time_frame>
    <description>From blood samples: protein levels.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Infection Viral</condition>
  <arm_group>
    <arm_group_label>COVID-19 infected patients</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>biological samples collection</intervention_name>
    <description>collection of whole blood samples, urine and stool samples, upper respiratory samples, post-mortem biopsies</description>
    <arm_group_label>COVID-19 infected patients</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole Blood Sample Upper respiratory sampling Urine and stool collection Post mortem biopsies
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients / caregivers treated at Bordeaux University Hospital for asymptomatic or
        symptomatic infection by SARS -CoV-2.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients / caregivers treated at Bordeaux University Hospital for asymptomatic or
             symptomatic infection by SARS -CoV-2

          -  men and women, adults and minors as well as pregnant or breastfeeding women

          -  patients who died following infection with SARS-CoV-2 (specific criterion for
             post-mortem biopsies)

          -  Be affiliated with or beneficiary of a social security scheme

          -  Free and informed consent obtained and signed by the patient

        Exclusion Criteria:

          -  Under guardianship or curatorship
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Isabelle PELLEGRIN</last_name>
    <phone>05 57 82 11 50</phone>
    <email>isabelle.pellegrin@chu-bordeaux.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Aurélie POUZET</last_name>
    <phone>05 57 82 17 31</phone>
    <email>aurelie.pouzet@chu-bordeaux.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Bordeaux</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isabelle PELLEGRIN</last_name>
      <phone>05 57 82 11 50</phone>
      <email>isabelle.pellegrin@chu-bordeaux.fr</email>
    </contact>
    <contact_backup>
      <last_name>Aurélie POUZET</last_name>
      <phone>05 57 82 17 31</phone>
      <email>aurelie.pouzet@chu-bordeaux.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 30, 2020</study_first_submitted>
  <study_first_submitted_qc>April 1, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 2, 2020</study_first_posted>
  <last_update_submitted>April 2, 2020</last_update_submitted>
  <last_update_submitted_qc>April 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 3, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>COVID-19</keyword>
  <keyword>SARS-CoV-2</keyword>
  <keyword>coronavirus</keyword>
  <keyword>biological samples</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Virus Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

